Approval of Rebyota, made by Ferring Pharmaceuticals, was based on findings from multiple randomized clinical trials.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Dec 1
The US Food and Drug Administration (FDA) announced yesterday that it has approved a fecal microbiota product for the prevention of recurrent Clostridioides difficile infection (CDI) in adults.
WHO researchers say the findings are of "grave concern" for Cambodia and from an international perspective.
In a large retrospective cohort study, increasing number of antibiotics courses, early timing, and broad-spectrum prenatal antibiotic exposure were associated with increased risk for childhood asthma, researchers reported today in Clinical Infectious Diseases.
The US Food and Drug Administration (FDA) has requested that manufacturers of bacitracin for injection voluntarily withdraw their products from the market.
CARB-X today announced an award of up to $6.8 million to Pattern Bioscience of Austin, Texas, to develop a rapid identification and antimicrobial susceptibility test (ID/AST) for drug-resistant pathogens.
According to the World Health Organization's (WHO's) online Ebola dashboard, a new case today lifts the outbreak total to 3,429 confirmed Ebola cases in the ongoing outbreak in the Democratic Republic of the Congo (DRC). The WHO also noted 123 probable cases, and 473 suspected cases still under investigation.
According to the World Health Organization's (WHO's) online Ebola dashboard, a new case recorded today raises the outbreak total to 3,430 confirmed cases in the ongoing outbreak in the Democratic Republic of the Congo (DRC). The WHO also noted 123 probable cases, and 524 suspected cases still under investigation.
Implementation of a global sewage-based antimicrobial resistance (AMR) surveillance system based on metagenomics sequencing could yield substantial and rapid benefits and be implemented quickly and at minimal expense, according to a paper today in Science.
According to the World Health Organization's (WHO's) online Ebola dashboard, only one new case of Ebola has been recorded in the Democratic Republic of the Congo (DRC) since Feb 6, raising the outbreak total to 3,431 confirmed cases. The WHO also noted 123 probable cases, and 441 suspected cases still under investigation.
Since the outbreak in North Kivu and Ituri provinces began in August 2018, 2,249 people have died from Ebola.
The World Health Organization (WHO) Ebola emergency committee that met today to review the outbreak situation in the Democratic Republic of the Congo (DRC) recommended continuing the public health emergency of international concern under International Health Regulations.
All three confirmed Ebola cases reported in the past week in the Democratic Republic of the Congo (DRC) involved known transmission chains, which is a good sign, but volatile situations still plague the outbreak region, the World Health Organization (WHO) said yesterday in its weekly situation report.
The United Kingdom yesterday announced the launch of a partnership with Nigeria, worth £10.7 million, to fight antimicrobial resistance (AMR) by improving public health surveillance, upgrading laboratory equipment, and training technicians.
A major reduction in the use of fluoroquinolones has driven a 12% decrease in total antibiotic use in Canadian hospitals in recent years, according to a new study in Antimicrobial Resistance and Infection Control.
CARB-X said today it has awarded Lytica Therapeutics, of Cambridge, Massachusetts, up to $5.3 million to develop antibacterial peptides that have broad activity against multidrug-resistant bacteria for treating lung and other infections.
The United Kingdom's Food Standards Agency (FSA) released two surveillance reports this week on antimicrobial resistance (AMR) in chicken meat.
York University this week announced a $2 million grant from the Canadian Institutes of Health Research to support the development of a global network to address infectious disease and antimicrobial resistance.
A new study by researchers from Harvard TH Chan School of Public Health suggests that outpatient prescribing of penicillins is associated with rates of mortality with sepsis in older US adults.
CARB-X announced today that it will award Peptilogics of Pittsburgh up to $2.56 million in funding to develop a new class of peptide antibiotics with broad activity against drug-resistant bacteria.
The International Society for Infectious Diseases' (ISID's) Program for Monitoring Emerging Diseases (ProMED) today announced that it is teaming up with Public Health England to boost global antimicrobial resistance (AMR) surveillance efforts.
No new cases of Ebola were reported in the Democratic Republic of the Congo (DRC) over the past week, according to an update yesterday from the World Health Organization (WHO), leaving the case count at 3,444. It marks the first time since the outbreak began that no new confirmed cases were reported over a 7-day period.
A population-based surveillance study estimates that there were nearly 23,000 cases of candidemia in the United States in 2017, researchers from the US Centers for Disease Control and Prevention (CDC) and several state health departments reported today in Clinical Infectious Diseases.
